Literature DB >> 25349052

Multi-layered haemorrhage secondary to retinal arterial macroaneurysm: a case report and review.

Mira Silbert Aumiller1, Jason Rinehart.   

Abstract

Retinal macroaneurysms are an acquired vascular anomaly primarily associated with advancing age and hypertension. Although a rare pathology, it is not uncommon for a patient with a macroaneurysm to present to the primary care optometrist. Macroaneurysms have various presentations and they constitute one of the few clinical entities that can produce preretinal, intraretinal, subretinal or vitreal haemorrhage or any combination thereof. A review of the pathophysiology, differential diagnosis and newest treatments will be provided. A 68-year-old Caucasian male patient with a history of a previously treated retinal macroaneurysm presented to the eye clinic with acute-onset visual loss in the same eye. The patient had a known diagnosis of hypertension and had been untreated by his primary care physician for one year. Dilated fundus examination revealed extensive multi-layered haemorrhaging along with significant macular oedema. A choroidal neovascular membrane was ruled out with fluorescein angiography. The patient was treated with monthly bevacizumab injections over a period of three months. At six months optical coherence tomography confirmed the resolution of macular oedema and the patient achieved a marked improvement in his visual acuity. Retinal arterial macroaneurysm is one of the few clinical entities with the potential to produce any combination of preretinal, intraretinal, subretinal and/or vitreal haemorrhage. When the macula is threatened, treatment must be pursued. Although laser treatment has traditionally been used, anti-vascular endothelial growth factor therapy has been used with promising visual outcomes.
© 2014 The Authors. Clinical and Experimental Optometry © 2014 Optometry Australia.

Entities:  

Keywords:  anti-VEGF; bevacizumab; hypertension; macroaneurysm; optical coherence tomography

Mesh:

Year:  2014        PMID: 25349052     DOI: 10.1111/cxo.12215

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  2 in total

1.  Foveal Exudative Macroaneurysm Treated with Intravitreal Ranibizumab.

Authors:  Carlos Menezes; Rui Carvalho; Carla Teixeira; José Alberto Lemos; Rita Gonçalves; Pedro Coelho; André Lima
Journal:  Case Rep Ophthalmol       Date:  2015-06-02

2.  Outcomes of combined treatments in patients with retinal arterial macroaneurysm.

Authors:  Chenghu Wang; Guofan Cao; Xiangzhong Xu; Jian Wang; Shu Zhang
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.